BAY CITY CAPITAL LLC

Insider Reports History

Location
San Francisco, CA
Signature
Bay City Capital LLC, a Delaware limited liability company, By: /s/ Fred Craves, Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BAY CITY CAPITAL LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1,129,490 $937,477 $0.8300 26 Oct 2021 Indirect
MADRIGAL PHARMACEUTICALS, INC. 10%+ Owner Common Stock 1,261 $307,583 $243.92 03 Dec 2021 Direct
MADRIGAL PHARMACEUTICALS, INC. 10%+ Owner Common Stock 0 $243.92 03 Dec 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 26 Oct 2021 Indirect

Insider Reports Filed by BAY CITY CAPITAL LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MDGL MADRIGAL PHARMACEUTICALS, INC. 03 Dec 2021 3 $0 4 10%+ Owner 07 Dec 2021, 15:30
XLO Xilio Therapeutics, Inc. 26 Oct 2021 5 +$5,000,000 4 10%+ Owner 26 Oct 2021, 17:02
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 20:49